Product NDC: | 59011-446 |
Proprietary Name: | Dilaudid HP |
Non Proprietary Name: | hydromorphone hydrochloride |
Active Ingredient(s): | 10 mg/mL & nbsp; hydromorphone hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59011-446 |
Labeler Name: | Purdue Pharma LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019034 |
Marketing Category: | NDA |
Start Marketing Date: | 19840111 |
Package NDC: | 59011-446-25 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (59011-446-25) > 25 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 59011-446-25 |
Proprietary Name | Dilaudid HP |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (59011-446-25) > 25 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 59011-446 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hydromorphone hydrochloride |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19840111 |
Marketing Category Name | NDA |
Labeler Name | Purdue Pharma LP |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |